ParkerVision Filing Motion to Terminate ITC Investigation Following Ruling to Disallow Key Evidence
Mar 13, 2017 11:31 am UTC| Business
JACKSONVILLE, Fla., March 13, 2017 -- ParkerVision, Inc. (Nasdaq:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced that in light of a recent ruling by the...
Parker Hannifin Celebrates 100 Years
Mar 13, 2017 11:31 am UTC| Business
CLEVELAND, March 13, 2017 -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today is celebrating the 100th anniversary of its founding on March 13, 1917 and has launched a...
Parker Hannifin Celebrates 100 Years
Mar 13, 2017 11:31 am UTC| Business
CLEVELAND, March 13, 2017 -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today is celebrating the 100th anniversary of its founding on March 13, 1917 and has launched a...
Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 13, 2017 11:31 am UTC| Business
– Opened two new INDs for wholly-owned SPEAR® T-cell therapies; Company now has four open INDs in 11 indications – – Received orphan designation, PRIME regulatory support and Breakthrough Therapy designation for NY-ESO...
Adaptimmune Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 13, 2017 11:31 am UTC| Business
– Opened two new INDs for wholly-owned SPEAR® T-cell therapies; Company now has four open INDs in 11 indications – – Received orphan designation, PRIME regulatory support and Breakthrough Therapy designation for NY-ESO...
Mar 13, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., March 13, 2017 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced that Celgene Corporation has designated the development candidate focused on MTAP (methylthioadenosine phosphorylase) deleted...
Mar 13, 2017 11:30 am UTC| Business
BASKING RIDGE, N.J., March 13, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining a select therapeutic development pipeline with an industry-leading...